Stryker stock falls on slower peripheral vascular, hip sales

Stryker's CFO Preston Wells reported supply chain issues in the peripheral vascular business and lower-than-expected hip sales in the current quarter at a healthcare conference. The company continues to work through manufacturing and supply challenges affecting its orthopedic and vascular device segments.